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e previously demonstrated that integrin-
dependent adhesion activates STAT5A, a
well known target of IL-3–mediated signaling.
Here, we show that in endothelial cells the active 
 
 
 
1 inte-
grin constitutively associates with the unphosphorylated
IL-3 receptor (IL-3R) 
 
 
 
 common subunit. This association
is not sufﬁcient for activating downstream signals. In-
deed, only upon ﬁbronectin adhesion is Janus Kinase 2
(JAK2) recruited to the 
 
 
 
1 integrin–IL-3R complex and
triggers IL-3R 
 
 
 
 common phosphorylation, leading to the
formation of docking sites for activated STAT5A. These
events are IL-3 independent but require the integrity of the
W
 
IL-3R 
 
 
 
 common. IL-3 treatment increases JAK2 activation
and STAT5A and STAT5B tyrosine and serine phosphory-
lation and leads to cell cycle progression in adherent
cells. Expression of an inactive STAT5A inhibits cell cycle
progression upon IL-3 treatment, identifying integrin-
dependent STAT5A activation as a priming event for IL-3–
mediated S phase entry. Consistently, overexpression of a
constitutive active STAT5A leads to anchorage-indepen-
dent cell cycle progression. Therefore, these data provide
strong evidence that integrin-dependent STAT5A activation
controls IL-3–mediated proliferation.
 
Introduction
 
Adhesion of endothelial cells to extracellular matrix is medi-
ated by the integrin family of cell surface receptors (Hynes,
2002). Integrins are heterodimers of an 
 
 
 
 and 
 
 
 
 subunit and
their binding to matrix proteins triggers multiple signaling
pathways, which regulate basic cell functions (Giancotti and
Ruoslahti, 1999; Damsky and Ilic, 2002; Howe et al., 2002;
Miranti and Brugge, 2002; Giancotti and Tarone, 2003). Integrin-
induced signaling also affects gene expression (de Fougerolles
and Koteliansky, 2002). Among the early genes responsive to
growth signals, c-fos gene has been proposed as a mediator of
cell cycle progression controlled by cell adhesion (Wary et al.,
1996). The signaling pathway leading to integrin-dependent
c-fos transcription is only partially known, and roles for the ac-
tivated Erk1/Erk2 MAPK (Wary et al., 1996) and the transcrip-
tional factor STAT5A have been proposed (Brizzi et al., 1999).
STAT5 is a known target of IL-3 (Ihle and Kerr, 1995;
O’Shea, 1997; Grimley et al., 1999), a T cell–derived cytokine
(Wimperis et al., 1989) that, besides promoting hematopoietic
progenitor cell proliferation and differentiation, acts as an in-
ducer of endothelial and smooth muscle cell migration and pro-
liferation and as a promoter of neoangiogenesis (Brizzi et al.,
1993, 2001; Korpelainen et al., 1995, 1996). Moreover, we
reported  that CD4/CD25/CD5 
 
 
 
 T cells infiltrating breast
cancer tissues also express IL-3, which by stimulating endothe-
lial cells can affect vessel assembly (Dentelli et al., 2004). IL-3
has also been found to act as survival factor for tumor-derived
endothelial cells (Deregibus et al., 2002), suggesting a pleiotro-
pic role for this cytokine in endothelial cell biology. IL-3 binds
to a heterodimeric receptor consisting of a ligand binding 
 
 
 
subunit and a 
 
 
 
 subunit that is shared with GM-CSF and IL-5
receptors and is denoted as 
 
 
 
 common (Reddy et al., 2000;
Geijsen et al., 2001). The type I cytokine receptor 
 
 
 
 common
has a large cytoplasmic domain that plays a pivotal role in
downstream signal transduction (Kitamura et al., 1991). IL-3R,
which lacks intrinsic kinase activity, interacts with and acti-
vates Janus Kinase 2 (JAK2) in response to ligand binding.
As a consequence, the 
 
 
 
 common subunit undergoes tyrosine
phosphorylation and cues signaling molecules such as MAPK,
the phosphatidylinositol 3-kinase, and the STATs (Reddy et al.,
2000; Geijsen et al., 2001). STAT5 proteins consisting of
STAT5A and STAT5B are the main targets of IL-3 signaling
(Mui et al., 1995a; Ihle, 2001). Upon cytokine stimulation,
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JAK2 phosphorylates STAT5 (Reddy et al., 2000) and the
phosphorylated STAT5 proteins dimerize and translocate into
the nucleus, where, by binding DNA, they activate target
genes including c-fos (Mui et al., 1996). In addition to this
JAK-catalyzed tyrosine phosphorylation, STAT5 may undergo
serine phosphorylation in the carboxy-terminal P(M)SP site
(Yamashita et al., 1998) in response to prolactin (Decker and
Kovarik, 2000). However, functional studies of the effects
of serine phosphorylation on STAT5’s transcriptional activity
have not provided a consistent picture.
In addition to the role played by STAT5 in cytokine re-
ceptor signaling, we reported that STAT5A becomes acti-
vated in endothelial cells upon cell matrix adhesion (Brizzi et
al., 1999). Also STAT1 has been implicated in regulation of
cell adhesion, spreading, and migration (Xie et al., 2001),
suggesting a pleiotropic role for the STAT pathway in adhe-
sion-dependent signaling.
In nonadherent hematopoietic cells, STAT5 is required
for IL-3–mediated cell proliferation (Mui et al., 1995b, 1996).
In addition, IL-3 triggers endothelial cell proliferation (Brizzi
et al., 1993; Mui et al., 1995b, 1996) and activates STAT5 to
induce in vivo neoangiogenesis (Dentelli et al., 1999, 2004),
suggesting that STAT5 could also regulate IL-3–dependent cell
cycle progression in vascular adherent cells. Here, we show
that integrin-dependent JAK2 and STAT5A activation are pre-
requisites for IL-3–mediated endothelial cell proliferation.
 
Results
 
The 
 
 
 
 common subunit of IL-3R stably 
interacts with the active 
 
 
 
1 integrin
 
It is well established that integrins trigger specific signaling
pathways by directly trans-activating growth factor receptors
(Moro et al., 1998; Miranti and Brugge, 2002; Schwartz and
Ginsberg, 2002; Giancotti and Tarone, 2003). We showed
that in endothelial cells integrins induce ligand-independent
STAT5A activation and c-fos gene expression (Brizzi et al.,
1999). As shown in Table I, adhesion of endothelial cells to
fibronectin (FN) in the absence of IL-3 is not sufficient to pro-
mote entry in the S phase of the cell cycle. Consistently, upon
adhesion, unlike c-fos mRNA expression, which is strongly up-
regulated (Fig. 1 A), cyclin D1 protein is not modified within
15 h of adhesion (Fig. 1 B, gray bars). Its expression is induced
by serum in adherent cells (Fig. 1 B, black bars), confirm-
ing that in primary cells expression of G
 
1
 
 phase cyclins re-
quires concomitant signals emanated from integrins and soluble
ligands (Assoian and Schwartz, 2001). Endothelial cells plated
on FN undergo both proliferation and migration in response to
IL-3 treatment (Table I), suggesting that IL-3 and its receptor
play a crucial role in regulating endothelial cell functions. The
fact that STAT5 is a well defined target of IL-3R signaling in
endothelial cells (Dentelli et al., 1999) prompted us to evaluate
the involvement of the IL-3R in mediating integrin-dependent
STAT5 activation. A likely mechanism through which inte-
grins can activate STAT5A may depend on cross talk between
 
 
 
1 integrin and the IL-3R 
 
 
 
 common. To investigate this possi-
bility, 
 
 
 
1 integrin and IL-3R 
 
 
 
 common were immunoprecipi-
tated (IP) from endothelial cell extracts and the immunoprecip-
itates were reciprocally immunoblotted (IB) as shown in Fig. 2 A
(top panels). Cell extract from MO7-E cells was IP with an an-
tiserum to IL-3R 
 
 
 
 common and used as positive control (
 
 
 
).
These experiments demonstrate that 
 
 
 
1 integrin associates with
the IL-3R 
 
 
 
 common, both in cells kept in suspension or adher-
ent to FN, indicating that these two molecules stably interact in
endothelial cells independently from the adhesive state. The
specificity of the association was also demonstrated by the loss
 
Table I.
 
 IL-3 triggers endothelial cell proliferation and migration
Control IL-3 bFGF
 
Percentage of cells in
S phase
6 
 
 
 
 1 15 
 
 
 
 2 18 
 
 
 
 2
Number of cells counted
upon 6 d of culture
 
a
 
3 
 
 
 
 2 22 
 
 
 
 2 39 
 
 
 
 3
Number of cells migrated 
across the membrane
12 
 
 
 
 2 48 
 
 
 
 3 54 
 
 
 
 4
 
Endothelial cells resuspended at 5 
 
 
 
 10
 
4
 
/ml were seeded on FN-coated dishes.
For the determination of the percentage of cells in S phase, triplicate cultures (five
individual experiments) were pulse labeled with [
 
3
 
H]TdR (4 
 
 
 
Ci/ml) for 1 h the
second day after the addition of 20 ng/ml IL-3 or 10 ng/ml bFGF, which was
used as positive control, and processed by autoradiography (Brizzi et al.,
1993). Cell proliferation was assessed 6 d after the addition of the indicated
growth factors by direct cell count on triplicate wells. The numbers are the
mean 
 
 
 
 SD of labeled or counted cells. The migration assay was performed
by the modified chambers technique (8-
 
 
 
m pore size filters FN coated) on
endothelial cells untreated or treated with 20 ng/ml IL-3 or 10 ng/ml bFGF,
which was used as positive control (Dentelli et al., 1999). The numbers represent
the mean 
 
 
 
 SD of cells counted per 10 fields (
 
 
 
200).
 
a
 
Cells 
 
 
 
 10
 
4
 
.
Figure 1. Adhesion-mediated c-fos gene mRNA and cyclin D1 protein
expression. (A) RNA from endothelial cells kept in suspension (S) or adherent
to FN for 30 min was subjected to Northern blot; c-fos mRNA level was
quantified by densitometric analysis. (B) Cell extracts from endothelial
cells kept in suspension (0) or let to adhere to FN in the presence or in the
absence of FCS for the indicated times were subjected to 12% SDS-PAGE
and IB with cyclin D1 antibodies. Cyclin D1 expression was quantified by
densitometric analysis and reported as the mean   SD of four indepen-
dent experiments. *, P   0.05 FN versus FN   serum. 
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of signal when the same filter was IB with the IL-3 
 
 
 
 common
antiserum preadsorbed with the immunizing peptide (Fig. 2 A,
bottom left). Moreover, no coimmunoprecipitation of IL-3R 
 
 
 
common was observed with a control antibody against 
 
 
 
2 mi-
croglobulin (Fig. 2 A, bottom right).
To investigate further the molecular mechanisms leading
to adhesion-independent constitutive association of IL-3R 
 
 
 
common with 
 
 
 
1 integrin, the hematopoietic MO7-E cells,
which express both IL-3R (Brizzi et al., 1994) and 
 
 
 
1 integrin,
was used. Consistent with the fact that in these cells 
 
 
 
1 integrin
is present as an inactive form that can be activated by bivalent
cations (Bazzoni et al., 1995; Mould et al., 1995; Humphries et
al., 2003), we found that the 
 
 
 
1 integrin was able to coimmuno-
precipitate the IL-3R 
 
 
 
 common only in cells treated with
Mn2
 
 
 
 (Fig. 3 A). These data suggest that activation of 
 
 
 
1 inte-
grin is a prerequisite for association with the IL-3R 
 
 
 
 common.
Flow cytometry analysis using mAb 12G10, recognizing one
epitope expressed only in the FN-competent 
 
 
 
1 integrin (Mould
et al., 1995), or mAb BV7, recognizing a constitutive 
 
 
 
1 inte-
grin epitope, was performed on MO7-E cells and endothelial
cells. As shown in Fig. 3 B, mAb 12G10 binds to MO7-E cells
only in the presence of the activating bivalent cation Mn2
 
 
 
(Fig. 3 B, compare c and d). In contrast, in endothelial cells the
12G10-recognizing epitope was already exposed in the absence
of any treatment (Fig. 3 B, e), indicating that a large majority of
the 
 
 
 
1 integrin expressed on the surface of endothelial cells was
in the active state. No staining was observed by incubating cells
with anti–IL-1
 
 
 
 (Fig. 3 B, a) as well as with preimmune IgG
(Fig. 3 B, a–e, left curve). Thus, IL-3R 
 
 
 
 common interacts
with 
 
 
 
1 integrin only in its active form, indicating that 
 
 
 
1 inte-
grin activation allows its association with the IL-3R.
 
Upon adhesion, phosphorylated JAK2 
and STAT5A associate with 
 
 
 
1 integrin–
IL-3R 
 
 
 
 common complex
 
To evaluate the role of the IL-3R 
 
 
 
 common in integrin-mediated
STAT5A activation, endothelial cells were kept in suspension or
plated on FN for different time intervals. Cell extracts were IP
with antibodies to the IL-3R 
 
 
 
 common subunit and IB with an-
tiphosphotyrosine antibodies. The 140-kD IL-3R 
 
 
 
 common be-
came phosphorylated within 20 min of adhesion and coprecipi-
tated with a phosphorylated band of 
 
 
 
90 kD in the same
conditions (Fig. 2 B), indicating that integrin-dependent adhe-
sion triggers IL-3R 
 
 
 
 common activation. To identify the 90-kD
phosphorylated band, the anti–IL-3R 
 
 
 
 common immunoprecip-
itates were divided in two aliquots, run on the same gel, and sep-
arately IB with anti–phospho-STAT5 and anti-STAT5A antibod-
ies. As depicted in Fig. 2 C, the 90-kD protein coprecipitating
with the IL-3R 
 
 
 
 common only in cells adherent to FN was most
likely the phosphorylated STAT5A. Moreover, the observation
that 
 
 
 
1 integrin coprecipitated with IL-3R 
 
 
 
 common and
STAT5A indicates that adhesion to FN led to the formation of a
macromolecular 
 
 
 
1 integrin–IL-3R 
 
 
 
 common–STAT5A com-
plex (Fig. 2 C). The specificity of this interaction was confirmed
by the inability of the antibody to STAT5A to recognize IP bands
when beads bound only to Sepharose protein A and not antibody
to IL-3R were used (Fig. 2 D). Thus, these data show that inte-
grin-mediated adhesion by phosphorylating the IL-3R 
 
 
 
 com-
mon creates a docking site for the phosphorylated STAT5A.
As shown in Fig. 3 A, in M07-E cells 
 
 
 
1 integrin–IL-3R
 
 
 
 common complex formation depends on integrin activation.
Therefore, we use these cells as a suitable model to answer the
question of whether or not 
 
 
 
1 integrin–IL-3R 
 
 
 
 common inter-
action represents a prerequisite for the activation of STAT5A.
The results reported in Fig. 3 C clearly show that STAT5A was
phosphorylated only in cells pretreated with Mn2
 
 
 
, a condi-
tion required for activating 
 
 
 
1 integrin and inducing its associ-
ation with the IL-3R 
 
 
 
 common (Fig. 3 A). Thus, these data
strongly support the possibility that at least in M07-E cells,
IL-3R–
 
 
 
1 integrin complex is essential for STAT5A activation.
Figure 2. FN-induced association of activated STAT5A with the constitutive
 1 integrin–IL-3R   common complex. (A) Cell extracts from starved en-
dothelial cells kept in suspension (S) or plated on FN-coated dishes (20
min) were immunoprecipitated (IP) with mAb TS2/16 to the  1 integrin
subunit, and the immunoprecipitates were divided in two aliquots. Western
blot was performed with IL-3R   common antibodies (top left) or with the
same antibodies preadsorbed on the recombinant IL-3R   common protein
(bottom left). In the absence of the positive signal, to reveal IgG, the latter
filter was overexposed. The same amount of cell extracts was IP with IL-3R  
common antibodies, the immunoprecipitate run on a 6% SDS-PAGE in
non-reducing conditions, and IB with  1 integrin mAb (top right). Parallel
experiments were IP with anti- 2 microglobulin antibodies. Filters were IB
with IL-3R   common antibodies (bottom right). (B) Cell extracts from en-
dothelial cells plated on FN-coated dishes for different times in the pres-
ence of 50  M pervanadate were IP with IL-3R   common antibodies and
IB with antiphosphotyrosine antibodies (  PY; top) and reprobed with IL-3R  
common antibodies (bottom). (C) Cell extracts from endothelial cells
plated as in A were IP with IL-3R   common antibodies, divided in two
aliquots, and IB with anti–phospho-STAT5, anti-STAT5A protein, and reim-
munoblotted with IL-3R   common antibody or  1 integrin mAb. (D) Cells
extracts treated as in A were IP with uncoupled or with STAT5A-coupled
Sepharose protein A beads and IB with STAT5A antibody. M07-E cell
extracts were used as positive control ( ). The results are representative of
four independent experiments.JCB • VOLUME 168 • NUMBER 7 • 2005 1102
On the contrary, the results obtained in endothelial cells shown
in Fig. 2 indicate that IL-3R– 1 integrin complex is required
but not sufficient for downstream signaling events.
We previously demonstrated that integrin-mediated adhe-
sion triggered JAK2 activation (Brizzi et al., 1999). Here, we
investigated the role of JAK2 in the formation of the  1 inte-
grin–IL-3R   common–STAT5A complex (Fig. 2 C). As posi-
tive control for the inhibitory effect of the JAK2 inhibitor
AG-490, M07-E cells were used (Fig. 4 A). Subsequently, en-
dothelial cells pretreated with 100 nM were kept in suspension
or plated on FN and cell extracts were IP with the antiserum to
the IL-3R   common. The anti–phospho-STAT5 immunoblot in
Fig. 4 B shows that the phosphorylated STAT5A did not coim-
munoprecipitate with the IL-3R   common in adherent cells
pretreated with AG-490. In addition, the finding that STAT5A
cannot be detected in the IL-3R   common immunoprecipitate
from cells pretreated with AG-490 sustains the possibility that
JAK2 kinase activity regulates both STAT5 recruitment and
activation (Fig. 4 B). Similarly, in the immunoprecipitates of
the IL-3R   common, the phosphorylated bands corresponding
to STAT5A and the IL-3R   common were not present when
the cells were pretreated with AG490 (Fig. 4 C). Moreover, by
immunoprecipitating with antibodies to the  1 integrin, JAK2
was found associated with the  1 integrin–IL-3R   common
complex only in cells adherent to FN (Fig. 4 D). Adhesion
to FN also triggers JAK2 tyrosine phosphorylation (Fig. 4
E). These data support a potential role of JAK2 in regulating
both adhesion-mediated IL-3R   common phosphorylation and
STAT5A recruitment and activation.
The intracellular domain of the IL-3R   
common is required for STAT5A 
recruitment by cell adhesion
To evaluate whether or not the intracellular region of the IL-3R  
common may act as a STAT5A docking site, HEK293 cells
were stably transfected with the full-length IL-3R   common
subunit or one of two Myc-tagged deletion mutants, the first
lacking the entire intracellular domain including the juxtamem-
brane region corresponding to the docking sites for JAK and
STAT proteins ( 455) and the second the intracellular region
corresponding to the amino acids 545–881 ( 544), still able to
activate receptor signaling (Sakamaki et al., 1992). The basal
adhesion-dependent activation of STAT5A was first evaluated
in Neo vector-transfected cells. As shown in Fig. 5 A, the anti–
phospho-STAT5 IB of total cell extracts revealed a faint band
corresponding to the activated STAT5, indicating that a mini-
mal STAT5A activation is detectable in these cells upon adhesion.
Figure 3. The IL-3R   common subunit as-
sociates with the active form of  1 integrin.
(A) Starved MO7-E cells incubated or not with
10 mM of bivalent Mn2  cations (Mn) with
( ) or without ( ) IL-3 were detergent ex-
tracted. Cell extracts were IP with  1 integrin
mAb or IL-3R   common antibodies and IB
with IL-3R   common antibodies. (B) MO7-E
cells untreated (a–c) or treated with 10 mM
Mn2  (d) were subjected to flow cytometry
analysis with IL-1  mAb (a) or preimmune IgG
(a–e, left curve) as negative controls, mAb
BV7 (b) or mAb 12G10 (c and d). Endothelial
cells were subjected to flow cytometry analysis
with mAb 12G10 (e). The data expressed as
relative cell number (y axis) plotted as a func-
tion of fluorescence intensity (x axis) are repre-
sentative of three experiments. (C) Extracts from MO7-E cells left untreated ( ) or treated with Mn2  ( ) were subjected to SDS-PAGE and IB with phospho-
STAT5 antibody and STAT5A antibody. Similar results were obtained in four individual experiments.
Figure 4. FN-dependent STAT5A phosphorylation and recruitment to the
IL-3R   common depends on integrin-mediated JAK2 kinase activity.
(A) Extracts from M07-E cells, untreated or treated with IL-3 with ( ) or
without ( ) 100 nM of JAK2 kinase inhibitor AG490, were IP with JAK2
antibody, IB with anti-PY, and reimmunoblotted with JAK2 antibodies.
(B and C) Extracts from endothelial cells kept in suspension or plated on
FN-coated dishes with ( ) or without ( ) 100 nM AG490 were IP with
IL-3R   common antibodies, divided in two aliquots, and run on 8% SDS-
PAGE. (B) Filter was IB with phospho-STAT5 antibody or STAT5A antibody
(top) and reimmunoblotted with IL-3R   common antibodies (bottom).
(C) Immunoblotting was performed with anti-PY antibodies (top) or IL-3R  
common antibodies. (D) Cell extracts from endothelial cells were IP with
 1 integrin mAb TS2/16 and IB with JAK2 antibodies (top) or IL-3R  
common antibody (bottom). (E) Cell extracts from endothelial cells with ( )
or without ( ) IL-3 were IP with JAK2 antibodies and subjected to SDS-
PAGE. Filters were IB with anti-PY antibodies or JAK2 antibodies. The results
are representative of three independent experiments.INTEGRIN CROSS TALK WITH IL-3R • DEFILIPPI ET AL. 1103
IL-3–treated M07-E cells were used as positive control (Fig. 5
A,  ). Subsequently, coimmunoprecipitation experiments were
performed on HEK293 cells expressing the full-length IL-3R  
common or one of the two mutants. As shown in Fig. 5 B, in
agreement with the data obtained in primary endothelial cells, in
response to adhesion tyrosine-phosphorylated STAT5A coim-
munoprecipitated with the IL-3R   common in HEK293 cells
expressing the full-length receptor. In contrast, phosphorylated
STAT5A was undetectable in the immunoprecipitates of the
 455 truncated form of the IL-3R   common (Fig. 5 C). Also in
these experiments IL-3–treated M07-E cells were used as posi-
tive control. Consistent with the ability of  544 mutant receptor
to trigger intracellular signaling (Sakamaki et al., 1992), it was
still able to recruit STAT5A (Fig. 5 C).
The transcriptional role of adhesion-induced STAT5A ac-
tivation and recruitment to the  1 integrin–IL-3R   common
complex was assayed by the electrophoretic mobility shift assay
(EMSA) using the Sis-inducible element of c-fos (SIE) sequence
as probe. The 
32P-labeled SIE sequence was incubated with nu-
clear extracts prepared from HEK293 cells expressing the wild-
type or the  455 truncated mutant plated on FN or kept in sus-
pension. The results reported in Fig. 5 D demonstrate that only
adhesion to FN induces the formation of a SIE-binding complex
in nuclear extracts from HEK293 cells expressing the full-length
IL-3R   common. The residual adhesion-dependent SIE-binding
complex observed in nuclear extracts from cells expressing the
 455 truncated form of the IL-3R   common is likely due to the
basal level of STAT5 activation reported in Fig. 5 A.
Although the  455 truncated form of the IL-3R   com-
mon lacked the ability to recruit STAT5A in response to adhe-
sion, it was still physically associated with the  1 integrin sub-
unit (Fig. 5 E), suggesting that the interaction between these
two molecules occurs through the extracellular or the trans-
membrane regions, as reported for the PDGF and VEGF recep-
tors (Borges et al., 2000). Therefore, these data define the IL-3R
  common subunit cytoplasmic domain as a docking site for
the activated STAT5A in response to adhesion.
IL-3–dependent STAT5A activation 
requires cell adhesion
Our experiments, performed in the absence of IL-3, show that in
response to adhesion, integrins by activating JAK2 cooperate
with the IL-3R   common for the activation of STAT5A. How-
ever, when IL-3 was added to endothelial cells plated on FN, not
only the level of JAK2 phosphorylation (Fig. 4 E) but also that
of STAT5 increased (Fig. 6 A). Kinetics analysis shows that, al-
though FN induced a transient STAT5A phosphorylation, IL-3
addition led to a persistent STAT5A phosphorylation, still de-
tectable within 120 min of treatment (Fig. 6 B). Because it has
been previously reported that in endothelial cells, upon IL-3
treatment, either STAT5A or STAT5B undergo activation
(Dentelli et al., 1999), endothelial cells kept in suspension or ad-
herent to FN were evaluated for STAT5A and STAT5B activa-
tion in response to IL-3. The results presented in Fig. 6 C show
that the addition of IL-3 to adherent cells induced an increase in
STAT5A phosphorylation, quantified by densitometric analysis
(Fig. 6 C, top). Moreover, the amount of STAT5A coimmuno-
precipitated with IL-3R   common was also increased in IL-3–
treated cells (unpublished data), suggesting that the activation of
STAT5A in the IL-3–mediated signaling is the result of a coop-
erative effect between adhesion and soluble ligand.
Unlike STAT5A, as we already showed (Brizzi et al.,
1999), STAT5B was not phosphorylated by integrin-mediated
adhesion, but underwent tyrosine phosphorylation when endothe-
lial cells adherent to FN were further stimulated with IL-3 (Fig. 6
C, right). These results indicate that in contrast with STAT5A,
whose activation depends on cell adhesion, STAT5B activation
strictly depends on IL-3, suggesting that adhesion and IL-3 recruit
different signaling targets to achieve IL-3–dependent full biologi-
cal response. Consistent with this possibility, we found that IL-3,
besides its ability to induce STAT5B tyrosine phosphorylation,
also triggered serine phosphorylation of STAT5B. By contrast,
neither adhesion alone nor adhesion plus IL-3 treatment were able
to induce serine phosphorylation of STAT5A (Fig. 6 D).
To analyze further the role played by adhesion in IL-3–
mediated activation of STAT5A and STAT5B, endothelial
cells were treated with IL-3 both in suspension and in adherent
conditions. As depicted in Fig. 6 E, we found that IL-3–dependent
Figure 5. The juxtamembrane domain of the IL-3R   common is required
for STAT5A recruitment by cell adhesion. HEK293 cells expressing the
Neo vector, the full-length IL-3R   common subunit (FL), and the myc-
tagged  455 or  544 mutants of the IL-3R   common subunit were replated
on FN-coated dishes for 20 min. (A) Cell extracts from Neo vector–trans-
fected cells were IB with antibodies to phosphorylated STAT5A. (B and C)
Cell extracts were IP with IL-3R   common antibodies (B) or mAb 9E10 to
the Myc epitope tag (C), IB with phospho-STAT5 antibody or STAT5A anti-
body (top), and reimmunoblotted with IL-3R   common antibodies (B) or
mAb 9E10 (C). (D) Nuclear cell extracts from HEK293 FL or  455 mutant,
kept in suspension (S) or plated on FN, were subjected to EMSA analysis
(left) and supershift assay (right). Arrows indicate the SIE complex and
supershift species. (E) Extracts from FL or  455 mutant were IP with  1
integrin mAb and IB with mAb 9E10 (left) or IL-3R   common antibodies
(right). As positive control ( ), IL-3–treated M07-E cells were used. The
results are representative of three independent experiments.JCB • VOLUME 168 • NUMBER 7 • 2005 1104
tyrosine phosphorylation of STAT5A and STAT5B as well as
their interaction with the IL-3R   common only occurred in
cells adherent to FN.
Integrin-dependent STAT5A activation is 
essential for IL-3–mediated cell cycle 
progression in adherent cells
Cell adhesion to extracellular matrix is a prerequisite for cell
cycle progression in non-transformed cells (Assoian, 1997).
Although STAT5A has been reported to be involved in IL-3–
dependent proliferation of hematopoietic cells (Mui et al.,
1996), its role in proliferation of adherent cells has not yet been
defined. To evaluate the role of STAT5A in regulating IL-3–
dependent cell cycle progression in adherent cells, we reconsti-
tuted the IL-3R by transfecting the IL-3R   subunit cDNA into
the HEK293 cells expressing the full-length IL-3R   common
subunit (HEK293 IL-3R). As reported in the previous section
for endothelial cells, also in these cells we were not able to de-
tect STAT5A activation in response to IL-3 in cells kept in sus-
pension (unpublished data). To assess whether or not HEK293
IL-3R cells stimulated with IL-3 progressed through the cell
cycle, cells were detached from the plates and either kept in
suspension or let to adhere to FN-coated dishes, and cell cycle
progression was evaluated upon IL-3 stimulation. As shown in
Table II, IL-3 treatment induced G1-S progression in FN-
adherent cells (percentage of cells in S phase: 30.5% sus-
pended cells vs. 40.4% adherent cells). Similar results were ob-
tained when cell proliferation was assessed by direct cell count
3 d after the addition of IL-3 (unpublished data). In contrast, IL-3
treatment was unable to induce the G1-S progression in cells
kept in suspension (percentage of cells in S phase: 27% un-
treated vs. 30.5% IL-3–treated), indicating that, consistent with
adhesion-dependent STAT5A activation, IL-3–mediated cell
cycle progression strictly depends on cell matrix adhesion.
To discriminate between STAT5A and STAT5B in medi-
ating IL-3–dependent cell cycle progression, plasmids contain-
ing dominant-negative constructs of STAT5 proteins (Mui et
al., 1996) or the Neo vector alone were transiently transfected
into HEK293 IL-3R cells. As shown in Table III, analysis of
the DNA content showed that expression of the dominant-neg-
ative STAT5B protein did not modify the percentage of cells in
the different phases of the cell cycle if compared with the Neo
vector–expressing cells. In contrast, in cells expressing the
dominant-negative form of STAT5A, IL-3 treatment was un-
able to increase the percentage of cells in S phase (Table III).
Collectively, these data identify STAT5A as a molecular
mediator of adhesion-dependent IL-3–mediated cell cycle pro-
gression. However, to further confirm a role of STAT5A in
this process, we evaluated if the expression of a constitutive
active STAT5A could restore the ability of cells to proliferate
Figure 6. IL-3–dependent STAT5 activation requires cell adhesion. (A) Ex-
tracts from endothelial cells kept in suspension or plated on FN-coated
dishes with ( ) or without ( ) IL-3 were IB with phospho-STAT5 antibody or
STAT5A antibody. Densitometric analysis of phospho-STAT5 is shown in the
top panel. The results are the mean   SD of four independent experiments;
*, P   0.05 control versus experimental groups. (B) Extracts were IP with
STAT5A antibodies and IB with phospho-STAT5 antibody or STAT5A anti-
body. (C) Cell extracts were divided into two aliquots and IP with specific
antibodies to STAT5A or STAT5B. The filters were IB with anti-PY and reim-
munoblotted with the anti-STAT5A or the anti-STAT5B antibodies. Densito-
metric analysis of STAT5A phosphorylation, performed as in A, is reported
in the top panel. The results are the mean   SD of four independent experi-
ments done on separate days; *, P   0.05 control versus experimental
groups. (D) Cell extracts were prepared and IP as in B. The filters were IB
with a phospho-serine STAT5 antibody (top) that recognizes P-Ser725 on
STAT5A or P-Ser730 on STAT5B (Pser) and reimmunoblotted with STAT5A
or STAT5B antibodies (bottom). (E) Cell extracts were separately IP with spe-
cific antibodies to STAT5A or STAT5B and IB with the anti-PY antibodies
(top), STAT5A/STAT5B antibodies (middle), or IL-3R   common antibodies
(bottom). The results are representative of four independent experiments.
Table II. IL-3–mediated cell cycle progression of HEK293 IL-3R–
expressing cells
G0/G1 S G2/M
%% %
(HEK293 IL-3R) S 65.5   8 27   4 6.5   1.5
(HEK293 IL-3R) S   IL-3 64.7   7 30.5   5 4.8   2
(HEK293 IL-3R) FN 61   3.5 30.7   5 8.3   4
(HEK293 IL-3R) FN   IL-3 51.6   6 40.4   4.5 8   3
HEK293 IL-3R cells serum starved for 24 h were kept in suspension or let to
adhere to FN-coated plates in the presence or absence of 20 ng/ml IL-3. After
18 h of IL-3 stimulation, the cells were fixed with ethanol and DNA was stained
with propidium iodide. The fluorescence related to DNA content was evaluated
by flow cytometry. The percentage of cells in each phase of the cell cycle was
determined by ModFit LT Software (Verity Software House Inc.). The numbers are
the mean   SD of three different experiments done on separate days, each
performed in triplicate.INTEGRIN CROSS TALK WITH IL-3R • DEFILIPPI ET AL. 1105
in suspension. HEK293 IL-3R–expressing cells were trans-
fected with the constitutive activated STAT5A construct or
with an empty vector, and a cell cycle progression assay was
performed in cells kept in suspension. As shown in Table IV,
HEK293 IL-3R cells transfected with the empty vector did not
progress into cell cycle. In contrast, cells transfected with the
constitutive active form of STAT5A acquired the ability to en-
ter into the cell cycle in suspension (percentage of cells in S
phase: 29.2% empty vector vs. 42% STAT5A-transfected), in-
dicating that the presence of the active form of STAT5A is
sufficient to trigger cell cycle progression to S phase in the ab-
sence of cell matrix adhesion and of IL-3. Indeed, when cells
expressing the constitutive active form of STAT5A were kept
in suspension or plated on FN, the addition of IL-3 was un-
able to further increase the percentage of cells in S phase
(Table IV). Together our data show that adhesion-dependent
STAT5A activation is a crucial event in the control of IL-3–
mediated proliferation.
Discussion
IL-3 is a well known activator of STAT5 signaling pathway in
hematopoietic cells (Mui et al., 1995b). Our previous data indi-
cate that, in endothelial cells, STAT5A is a target of integrin-
mediated cell matrix interaction (Brizzi et al., 1999), as well
as of IL-3 (Dentelli et al., 1999). In the present study, we dis-
sect the molecular mechanisms leading to integrin-dependent
STAT5A activation and we demonstrate that, in endothelial
cells,  1 integrin cooperates with the IL-3R   common to inte-
grate adhesion- and cytokine-mediated signals. In particular,
the IL-3R   common associates with the activated  1 inte-
grin and, only upon adhesion, acquires the ability to recruit
STAT5A. Cell matrix adhesion is also required to induce
JAK2 tyrosine phosphorylation and recruitment to the  1 inte-
grin–IL-3R   common complex. Moreover, we also identify
STAT5A as a crucial molecular target of adhesion-dependent
IL-3–mediated signaling leading to cell cycle entry.
Integrins and tyrosine kinase receptors, such as PDGF,
insulin, and EGF receptors, physically interact on the cell
membrane, as indicated by formation of macromolecular com-
plexes (Vuori and Ruoslahti, 1994; Miyamoto et al., 1996;
Sundberg and Rubin, 1996; Schneller et al., 1997; Moro et al.,
2002). Our data first report the association of  1 integrin and
the IL-3 cytokine receptor, indicating that also receptors devoid
of tyrosine kinase activity can cross talk with integrins.  1 inte-
grin specifically associates with the IL-3R   common in an ad-
hesion-independent stable complex in the absence of IL-3. Al-
though we cannot exclude that additional membrane molecules
may interplay with this complex, our experimental conditions
(i.e., serum deprivation, absence of soluble growth factors)
ruled out the possibility that exogenous soluble factors can trig-
ger this association. Moreover, the finding that the  1 integrin–
IL-3R   common complex is found in primary cells indicates
that this event represents a physiological condition. The trun-
cated form of the IL-3R   common, which lacks the cytoplas-
mic domain ( 455), is still able to interact with the  1 integrin
subunit, suggesting that this interaction might occur either
through the transmembrane or the extracellular domains, as de-
scribed by the model proposed for the constitutive interaction
of   3 integrin subunit with the PDGF or VEGF receptors
(Borges et al., 2000). However, comparing the expression of
the activated epitope of the  1 integrin in MO7-E cells with en-
dothelial cells, we can conclude that the activation state of  1
integrin is an essential step for its association with the IL-3R  
common. These data provide the first evidence of the relevance
of  1 integrin activation in mediating the interaction with other
membrane-associated receptors.
Integrin growth factor receptor cooperation has been ex-
tensively demonstrated, showing that integrins can regulate
receptor functions including transactivation, receptor coor-
dination and compartmentalization, and downstream signaling
Table III. Effect of dominant-negative STAT5A and STAT5B expression 
on IL-3–mediated HEK293 IL-3R cell cycle progression
G0/G1 S G2/M
%% %
(HEK293 IL-3R   Neo
vector) FN
61   2 31   38    2
(HEK293 IL-3R   Neo
vector) FN   IL-3
53   3 38.5   4 8.5   2
(HEK293 IL-3R    
STAT5A) FN
62.5   3 30   2 7.5   1.5
(HEK293 IL-3R    
STAT5A) FN   IL-3
63.3   1 29.2   2 8.5   3
(HEK293 IL-3R    
STAT5B) FN
60   2 30.5   2.5 9.5   2
(HEK293 IL-3R    
STAT5B) FN   IL-3
51.6   1 39   4 9.4   2
HEK293 IL-3R cells, transiently transfected with the empty vector (Neo vector) or
with dominant-negative STAT5A ( STAT5A) or STAT5B ( STAT5B) constructs,
were serum starved for 24 h and let to adhere to FN-coated plates in the absence
or presence of 20 ng/ml IL-3. After 18 h of stimulation, the cells were fixed with
ethanol and DNA was stained with propidium iodide. The fluorescence related
to DNA content was evaluated as described in Table II. The numbers are the
mean     SD of three different experiments done on separate days, each
performed in triplicate.
Table IV. The constitutive active 1*6 STAT5A protein induces 
adhesion-independent cell cycle progression
G0/G1 S G2/M
%% %
(HEK293 IL-3R   Neo
vector) S
63.3   8 29.2   4 7.5   1.5
(HEK293 IL-3R  
1*6 STAT5A) S
53.2   7 42   5 4.8   2
(HEK293 IL-3R  
1*6 STAT5A) S   IL-3
52.3   5 44.9   4 2.9   3
(HEK293 IL-3R  
1*6 STAT5A) FN
57.5   6 40.2   3 2.3   2
(HEK293 IL-3R  
1*6 STAT5A) FN   IL-3
58   5 39.7   4 2.3   2
HEK293 IL-3R cells, transfected with the empty vector (Neo vector) or with the
constitutive activated STAT5A construct (1*6 STAT5A), were serum starved for
24 h and kept in suspension or let to adhere to FN-coated plates in the presence
or absence of 20 ng/ml IL-3. Cell cycle progression was assayed on ethanol-
fixed cells. DNA was stained with propidium iodide. The fluorescence related to
DNA content was evaluated as described in Table II. The numbers are the mean
  SD of three different experiments done on separate days, each performed in
triplicate.JCB • VOLUME 168 • NUMBER 7 • 2005 1106
(Miranti and Brugge, 2002; Schwartz and Ginsberg, 2002; Ya-
mada and Even-Ram, 2002). In fact, strong evidence indicates
that integrin- and tyrosine kinase receptor–dependent signals
need to be integrated at various levels to induce cell prolifera-
tion. However, few data are available on integrin cross talk
with cytokine receptors on murine hematopoietic cells (Kanda
et al., 2003). Our experiments demonstrate that in endothelial
cells the constitutive interaction between  1 integrin and the
IL-3R   common is not sufficient for inducing downstream
signaling events. However, binding and phosphorylation of
JAK2, phosphorylation of IL-3R   common, as well as activa-
tion of STAT5A are strictly dependent on matrix ligand occu-
pancy of integrins, which in turn impart a stringent control to
the action of the IL-3R determining if cells proliferate rather
then undergo growth arrest. Moreover, the results obtained by
pharmacological inhibition of JAK2 kinase activity are consis-
tent with an essential role of JAK2 kinase for adhesion-depen-
dent IL-3R   common phosphorylation, recruitment, and acti-
vation of STAT5A.
Deletion of the membrane proximal region of the IL-3R
  common results in loss of activation of JAK2 (Quelle et al.,
1994). Upon JAK2 activation, the IL-3R   common becomes
phosphorylated and acquires the ability to bind several signal
transducing proteins, including STAT5 (Chin et al., 1996;
Durstin et al., 1996; Woodcock et al., 1996). Indeed, we report
here that the juxtamembrane deletion mutant  455 of the IL-
3R   common failed to recruit STAT5A upon adhesion, dem-
onstrating that this region, possibly because of the lack of
JAK2 kinase binding and activation (Reddy et al., 2000), is not
only required for the IL-3 biological response in hematopoietic
cells but also for integrin-mediated signaling.
Integrin signaling by itself regulates cell functions, such as
cytoskeletal organization, whereas in cooperation with growth
factor receptors controls cell migration and cell cycle progres-
sion. In fact, signals from integrins intimately coordinate with
pathways activated by growth factors at multiple steps during
cell proliferation (Assoian, 1997). The molecular mechanisms
involved in such events include integrin-dependent activation of
growth factor receptors (Moro et al., 2002), enhancement of
growth factor signals (Miyamoto et al., 1996; Short et al., 1998),
recruitment of crucial transducing proteins to membrane cyto-
skeletal complexes (Del Pozo et al., 2002), and enhancement of
nuclear translocation of transcriptional regulators (Aplin et al.,
2001). Our data show that JAK2, the IL-3R   common subunit,
and STAT5A are phosphorylated by integrin-dependent adhe-
sion in the absence of ligands. However, these signaling events
are further increased by the addition of soluble IL-3. These re-
sults provide evidence for a strong cooperation between inte-
grins and IL-3R and suggest that integrin-mediated adhesion, by
inducing partial activation of JAK2 and STAT5A, may “prime”
the cells to a full activation induced by the ligand.
IL-3 promotes endothelial cell proliferation (Brizzi et al.,
1993). Our data show that cell adhesion to FN in the absence of
IL-3 leads to STAT5A activation but does not allow cell cycle
progression, indicating that, as previously reported (Moro et
al., 1998), integrin-dependent activation of JAK2/STAT5A is
not sufficient, per se, to sustain cell proliferation. Consistently,
the addition of IL-3 confers ability to undergo cell cycle pro-
gression. Interestingly, this occurred only in adherent condi-
tions because IL-3 was not able to stimulate proliferation of
cells kept in suspension, indicating that cell cycle progression
is controlled by multiple consequential steps regulated by both
matrix attachment and cytokine receptor ligands.
So far, very few data are available on signaling pathways
that are specifically controlled by integrin-mediated anchorage.
Herein, we demonstrate that JAK2 and STAT5A are phosphor-
ylated by adhesion and that their phosphorylation increases
when IL-3 is added to endothelial cells. Interestingly, IL-3 acti-
vates JAK2 or STAT5A only in adherent but not in suspended
cells, indicating that these molecules represent specific molec-
ular targets of adhesion-mediated signaling.
We previously reported that IL-3 activates STAT5B in en-
dothelial cells (Dentelli et al., 1999). Here, we show that adhe-
sion does not trigger STAT5B activation. However, when IL-3
is added to adherent cells, STAT5B is phosphorylated both on
tyrosine and serine 730. The functional role of STAT5 serine
phosphorylation is still unclear (Decker and Kovarik, 2000).
Our data showing that STAT5A is not phosphorylated on serine
725 either upon adhesion or in response to IL-3 and that cells
expressing dominant-negative STAT5A fail to progress in S
phase upon IL-3 suggest that phosphorylation on tyrosine rather
than on serine is a crucial event for integrating the signals in-
duced by integrin-mediated adhesion and IL-3. Moreover, ex-
pression of the constitutive active form of STAT5A rescues cell
cycle progression in cells kept in suspension, indicating that
STAT5A renders the cells independent from the adhesive sig-
naling required for ligand-induced biological response. Thus,
STAT5A activation is a crucial step in the cooperative pathways
leading to anchorage-dependent IL-3–mediated cell growth.
The present work, focused on the cooperative role of inte-
grins in cytokine receptor signals in adherent cells, provides a
molecular mechanism to explain how integrins control cell
cycle progression in response to the ligand by cross talking
with the IL-3R. In addition, we demonstrate that activation of
STAT5A overcomes the requirement of cell adhesion and IL-3
stimulation to induce proliferative signals in adherent cells,
providing evidence that dysregulation of STAT5A activation,
by overcoming anchorage dependence, may induce inappropri-
ate proliferative signals and favor tumorigenesis.
Materials and methods
Reagents and antibodies
FN was purified from human plasma as previously described (Defilippi et
al., 1994). M199 medium (endotoxin tested), BSA, and protein A–Seph-
arose were all obtained from Sigma-Aldrich. Bovine calf serum (endotoxin
tested) was obtained from Hyclone. RPMI medium, G418, and lipofec-
tin reagents were purchased from Invitrogen. Trypsin was obtained from
Difco Laboratories.  -[
32P]dCTP, [
3H]TdR, nitrocellulose, HRP protein A, mo-
lecular weight markers, poly(dIdC):poly(dIdC), HRP-conjugated secondary
antibodies, fluorescein-labeled anti–mouse IgG, and the ECL reagent were
obtained from Amersham Biosciences. hIL-3 was a gift from Sandoz
Pharma LTD. bFGF was obtained from Euro Clone. The JAK2 kinase inhibitor
AG490 was purchased from Calbiochem.
Polyclonal IL-3R   common antibody has been described previously
(Dentelli et al., 1999). The mAbs TS2/16 (American Type Culture Collec-
tion), BV7 (Immunological Science), and 12G10 (gift of M. Humphries,INTEGRIN CROSS TALK WITH IL-3R • DEFILIPPI ET AL. 1107
University of Manchester, Manchester, UK) to the human  1 integrin sub-
unit and mAb 9E10 to the Myc epitope tag (American Type Culture Col-
lection) were affinity purified on protein A–Sepharose and their purity was
higher than 95%. mAb PY20 to phosphotyrosine was purchased from
Transduction Laboratories (Becton Dickinson). The anti–phospho-STAT5 (ty-
rosine 694/699) antibody was obtained from Cell Signaling and the
anti–phospho-STAT5 (serine725/730) antibody was obtained from Upstate
Biotechnology. The antibody to cyclin D1, JAK2, IL-1 , and  2 microglobulin
were purchased from Santa Cruz Biotechnology, Inc.
Cell culture and transfection
Endothelial cells were isolated from human umbilical cord vein as de-
scribed previously (Brizzi et al., 1993). MO7-E were grown as reported in
Avanzi et al. (1990) and Brizzi et al. (1994). HEK293 human epithelial
cells (American Type Culture Collection) were stably transfected with Neo
vector, the full-length IL-3R   common, or one of the IL-3R   common de-
leted mutants ( 544 and  455; gifts of A. Miyajima, Teikyo University
Biotechnology Research Center, Kanagawa, Japan; Sakamaki et al.,
1992) by the lipofectin methods and selected with G418. Full-length IL-
3R   common–expressing cells were also transfected with the cDNA
for the IL-3R   subunit (Kitamura et al., 1991; provided by T. Kitamura,
Tokyo University of Science, Tokyo, Japan) and selected with puromycin
(HEK293 IL-3R). Activated form of STAT5 (1*6 STAT5A; Onishi et al.,
1998) or dominant-negative STAT5A or STAT5B constructs (Mui et al.,
1996) were transiently transfected.
Evaluation of cell surface expression of active  1 integrin subunit
MO7-E and confluent endothelial cells were starved for 18 h, put in sus-
pension by 10 mM EDTA treatment, labeled with 10  g/ml mAb 12G10,
mAb BV7, mAb to IL-1  (negative control), or with a preimmune mAb for
30 min at 4 C, washed twice in PBS, and incubated with 10  g/ml of flu-
orescein-labeled anti–mouse IgG for the same time. Cell surface expres-
sion of  1 integrin subunit was evaluated by flow cytometry (FACScan;
Becton Dickinson).
Adhesion experiments
Tissue culture plates were coated with 20  g/ml FN by overnight incuba-
tion as described previously (Moro et al., 1998). Starved HEK293 and en-
dothelial cells were detached by 10 mM EDTA treatment and immediately
plated on the tissue culture plates for the indicated times (Moro et al.,
2002). When indicated, 50  M pervanadate was added. Cells were de-
tergent extracted in lysis buffer (1% Triton X-100, 50 mM Pipes, pH 6.8,
100 mM NaCl, 5 mM MgCl2, 300 mM sucrose, 5 mM EGTA, 2 mM
sodium orthovanadate, 1 mM PMSF, 10  g/ml leupeptin, 0.15 U/ml trypsin
inhibitory U/ml aprotinin, and 1  g/ml pepstatin).
Immunoprecipitation, SDS-PAGE, and immunoblotting
Equal amounts of cell extracts were subjected to SDS-PAGE or IP with
the indicated antibodies and processed as previously described (Brizzi
et al., 1999). The blots were incubated overnight with the indicated
antibodies and revealed by HRP-conjugate/chemiluminescent detection
method ECL.
Preparation of nuclear extracts and gel retardation assay
Nuclear extracts from transfected HEK293 cells were prepared as de-
scribed by Sadowski et al. (1993). EMSA analysis was performed as de-
scribed in Brizzi et al. (1999). The oligonucleotides used were as follows:
G GGG CAT TTC CCG TAA ATC and G GGG GAT TTA CGG GAA ATG
corresponding to the SIE (Zhong et al., 1994).
Northern blot analysis of c-fos mRNA expression
Cytoplasmic RNA was isolated according to Chomczynski and Sacchi
(1987) and Northern blot analysis was performed according to stan-
dard methods (Brizzi et al., 1993). c-fos hybridization was quantified by
densitometric analysis using a molecular imager (model GS-250; Bio-
Rad Laboratories).
Cell proliferation and migration assays
Cell proliferation and migration assays reported in Table I were per-
formed as described previously (Brizzi et al., 1993; Dentelli et al., 1999).
Cell cycle analysis
Endothelial and HEK293 IL-3R cells were kept in suspension or let to ad-
here to FN-coated dishes with or without IL-3 or bFGF (positive control).
After 18 h, cells were fixed with 70% ethanol, processed for propidium
iodide fluorescence, and analyzed with FACScan.
Statistical analysis
The results are representative of at least three independent experiments
performed in triplicate. Densitometric analysis using a molecular imager
was used to calculate differences in the fold induction of protein activation
or expression. Significance of differences between experimental and
control values was calculated using ANOVA with Newman-Keuls multi-
comparison test.
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